Pub. Date : 2022 Mar 9
PMID : 35328215
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Noteworthy are BRAF and RET/PTC alterations already validated as targets of Dabrafenib-mesylate, Pralsetinib and Selpercatinib. | Dabrafenib mesylate | ret proto-oncogene | Homo sapiens |
2 | Noteworthy are BRAF and RET/PTC alterations already validated as targets of Dabrafenib-mesylate, Pralsetinib and Selpercatinib. | Dabrafenib mesylate | ret proto-oncogene | Homo sapiens |